STAT’s biotech columnist Adam Feuerstein and cancer journalist Angus Chen report on the crossroads of drug development, business, Wall Street, and biotechnology at the American Society of Oncology annual meeting. The event saw a surge in interest for new breast cancer treatments.
A new round of promising breast cancer drugs is about to hit the market, but there’s a catch – many existing treatments are no longer effective against certain types of breast cancer. Researchers are scrambling to develop new therapies to meet the growing demand from patients struggling with this devastating disease.
Adam Feuerstein and Angus Chen provide an in-depth look at the latest developments and the challenges faced by researchers in their quest for effective treatments. The duo’s reporting also touches on issues related to equity and access to cancer care.
For the latest updates on cancer news, sign up for STAT’s Cancer Briefing newsletter here.
Source: https://www.statnews.com/2025/05/31/asco-day-two-cancer-meeting-chicago